Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文
Sign Up
Log in
Synmosa Biopharma Corp banner
S

Synmosa Biopharma Corp
TPEX:4114

Watchlist Manager
Synmosa Biopharma Corp
TPEX:4114
Watchlist
Price: 29.2 TWD 0.52%
Market Cap: NT$16.1B
Write Note Create Alert Ask AI

Intrinsic Value

Is Synmosa Biopharma Corp undervalued or overvalued?

See the intrinsic value estimate for Synmosa Biopharma Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.

Intrinsic value calculated as an equal blend of DCF
Locked
and Multiples
Locked

Do our valuations actually work? See backtest results .

Synmosa Biopharma Corp Intrinsic Value
LOCKED
Unlock
Today vs. history

4114 looks undervalued.
But is it cheap by its own standards?

See how today’s valuation compares with 4114’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor Synmosa Biopharma Corp
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Intrinsic Value Locked
Current Price NT$29.2
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to Synmosa Biopharma Corp

Fundamental Analysis

Financials
Efficiency

Earnings Waterfall
Synmosa Biopharma Corp

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Continue Research

Summary
intrinsic value, competitors valuation, and company profile.
DCF Valuation
stock valuation using Discount Cash Flow valuation method.
Relative Valuation
stock valuation using valuation multiples.
Wall St Estimates
price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Discover More
What is the Intrinsic Value of one Synmosa Biopharma Corp stock?

The intrinsic value for Synmosa Biopharma Corp (4114) under the Base Case is hidden TWD.

Is Synmosa Biopharma Corp stock undervalued or overvalued?

Compared with the current market price of 29.2 TWD, the stock appears hidden.

Back to Top
ALPHA SPREAD
Follow us
Join 360,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.